TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 12/14/23

2023-12-14 02:41:45 ET Japan ( NKY:IND ) -0.73%. Japan data: October Industrial Production (final) +1.3% (prior +0.5%). Japan October Machinery orders +0.7% m/m (vs. expected -0.5%). Markets also turned cautious ahead of the Bank of Japan’s policy meetin...

2023-12-13 02:47:25 ET More on Asia Tactical Investment System For S&P 500 - Financial Stress Index (Part 4) Asian markets mixed as investors await U.S. inflation numbers For further details see: Asian markets mixed as investors remain cautious ahead of Fed d...

2023-12-12 13:17:41 ET More on Johnson & Johnson Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Stocks To Watch: Big Week On Tap For McDonald's, Shopify, GameStop, And Johnson & Johnson Johnson & Johnson: Sleep Well At Night With The Only AAA-Rate...

2023-12-12 03:49:29 ET Summary Today, we take a deeper look at Denali Therapeutics, a biotech company focused on developing treatments for neurodegenerative and lysosomal storage diseases. Denali's developmental focus has drawn several collaboration partnerships from much larger d...

2023-12-12 02:45:02 ET More on Asia Bank of Japan: Last Man Standing With Negative Interest Rate Policy - May End Soon BOJ talk fuels bets on Japan exiting negative rate policy this month For further details see: Asian markets mixed as investors await U.S. inflat...

2023-12-11 15:41:33 ET Summary BioCryst faces heightened competition in the HAE market due to Pharvaris' positive CHAPTER-1 study of deucrictibant. Despite strong Q3 2023 revenues, BioCryst's long-term debts cast a shadow over its financial stability. The market reacted to Pha...

2023-12-11 11:40:56 ET More on Seattle Genetics, Takeda Pharmaceutical, etc. Takeda Pharmaceutical Company Limited (TAK) Q2 2023 Earnings Call Transcript Seagen's Acquisition: EU Approval And Potential Upside Takeda: Why I'm Staying Bearish On This Generic Drug Divid...

2023-12-11 02:28:13 ET Japan ( NKY:IND ) +1.50% . Japan’s machine tool orders declined 13.6% year-on-year to JPY 115,884 million in November 2023, easing from October’s 20.6% contraction. Investors also scaled back bets of interest rate hikes from the Ban...

2023-12-08 03:00:14 ET More on Asia Bank of Japan: Last Man Standing With Negative Interest Rate Policy - May End Soon BOJ talk fuels bets on Japan exiting negative rate policy this month Japan's factory activity contracts for the sixth straight month in November ...

2023-12-07 23:57:14 ET Summary MoonLake Therapeutics is a clinical-stage biopharmaceutical company developing nanobody-based therapies for inflammatory diseases. Their lead product candidate, Sonelokimab, has shown best-in-class potential in treating Hidradenitis suppurativa and P...